A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99-04)

被引：0
|
作者：
Okawara, GS
Winter, K
Donohue, JH
Pisters, PWT
Crane, CH
Greskovich, JF
Anne, PR
Bradley, JD
Willet, C
Ajani, JA
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Radiat Therapy Oncol Grp Headquarters, Philadelphia, PA USA
[3] Mayo Clin, Rochester, MN USA
[4] MD Anderson Canc Ctr, Houston, TX USA
[5] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[6] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[7] Washington Univ, Sch Med, St Louis, MO USA
[8] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：312S / 312S
页数：1
相关论文
共 50 条
  • [1] Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial
    Mornex, Francoise
    Girard, Nicolas
    Scoazec, Jean-Yves
    Bossard, Nadine
    Ychou, Marc
    Smith, Denis
    Seitz, Jean-Francois
    Valette, Pierre-Jean
    Roy, Pascal
    Rouanet, Philippe
    Ducreux, Michel
    Partensky, Christian
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (05): : 1471 - 1478
  • [2] Multiinstitutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma
    Klautke, G
    Fietkau, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (04) : 268 - 270
  • [3] A phase II single arm trial of preoperative chemoradiotherapy in borderline resectable esophageal cancer
    Chilukuri, S.
    Laskar, S.
    Ketayun, Ardeshir D.
    Mistry, R.
    Pramesh, C.
    Mohandas, K.
    ANNALS OF ONCOLOGY, 2007, 18 : VII47 - VII47
  • [4] Preoperative radiotherapy and docetaxel in resectable pancreatic adenocarcinoma:: A phase II trial.
    Viret, F.
    Ychou, M.
    Moutardier, V.
    Magnin, V.
    Rouanet, P.
    Monges, G.
    Azria, D.
    Turrini, O.
    Gonçalves, A.
    Giovannini, M.
    Delpero, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 202S - 202S
  • [5] Comparison of Overall Survival Between Preoperative Chemotherapy and Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma
    Mokdad, Ali A.
    Minter, Rebecca M.
    Yopp, Adam C.
    Porembka, Matthew R.
    Wang, Sam C.
    Zhu, Hong
    Augustine, Mathew M.
    Mansour, John C.
    Choti, Michael A.
    Polanco, Patricio M.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12): : 1468 - 1475
  • [6] Neoadjuvant chemotherapy for resectable adenocarcinoma of the panctreatic head - a prospective phase II trial
    Pestalozzi, B. C.
    Heinrich, S.
    Schafer, M.
    Pierre-Alain, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma
    Ajani, JA
    Mansfield, PF
    Janjan, N
    Morris, J
    Pisters, PW
    Lynch, PM
    Feig, B
    Myerson, R
    Nivers, R
    Cohen, DS
    Gunderson, LL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 2774 - 2780
  • [8] Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
    M. C. J. Anderegg
    P. C. van der Sluis
    J. P. Ruurda
    S. S. Gisbertz
    M. C. C. M. Hulshof
    M. van Vulpen
    N. Haj Mohammed
    H. W. M. van Laarhoven
    M. J. Wiezer
    M. Los
    M. I. van Berge Henegouwen
    R. van Hillegersberg
    Annals of Surgical Oncology, 2017, 24 : 2282 - 2290
  • [9] Preoperative Chemoradiotherapy Versus Perioperative Chemotherapy for Patients With Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma
    Anderegg, M. C. J.
    van der Sluis, P. C.
    Ruurda, J. P.
    Gisbertz, S. S.
    Hulshof, M. C. C. M.
    van Vulpen, M.
    Mohammed, N. Haj
    van Laarhoven, H. W. M.
    Wiezer, M. J.
    Los, M.
    Henegouwen, M. I. van Berge
    van Hillegersberg, R.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) : 2282 - 2290
  • [10] A phase II study of perioperative mFOLFOX chemotherapy plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (GEJ), and stomach
    Sun, Weijing
    Saeed, Anwaar
    Al-Rajabi, Raed Moh'd Taiseer
    Kasi, Anup
    Veeramachaneni, Nirmal K.
    Al-Kasspooles, Mazin Mazin
    Baranda, Joaquina Celebre
    Phadnis, Milind
    Godwin, Andrew K.
    Olyaee, Mojtaba
    Madan, Rashna
    Nagji, Alykhan
    Williamson, Stephen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345